Sign In
Buy NVZMY
$65.04
-0.650 (-0.99%)
At Close: Jul 31, 2026
ASH vs. NVZMY: Which Stock Is the Better Value Option?
12:46pm, Monday, 22'nd Jul 2024
Investors looking for stocks in the Chemical - Specialty sector might want to consider either Ashland (ASH) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?
12:41pm, Wednesday, 17'th Apr 2024
Investors looking for stocks in the Chemical - Specialty sector might want to consider either Mativ Holdings (MATV) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a bet
MATV or NVZMY: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 01'st Apr 2024
Investors interested in Chemical - Specialty stocks are likely familiar with Mativ Holdings (MATV) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for the
Are Basic Materials Stocks Lagging Novozymes (NVZMY) This Year?
10:41am, Tuesday, 19'th Mar 2024
Here is how Novozymes A/S (NVZMY) and Paladin Energy (PALAF) have performed compared to their sector so far this year.
MATV vs. NVZMY: Which Stock Is the Better Value Option?
12:41pm, Thursday, 14'th Mar 2024
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Mativ Holdings (MATV) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
10:46am, Friday, 01'st Mar 2024
Here is how Novozymes A/S (NVZMY) and Paladin Energy (PALAF) have performed compared to their sector so far this year.
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 27'th Feb 2024
Investors looking for stocks in the Chemical - Specialty sector might want to consider either Mativ Holdings (MATV) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a bet
Invitation to an extraordinary shareholders' meeting of Novozymes A/S
04:00am, Friday, 09'th Feb 2024
An extraordinary shareholders' meeting of Novozymes A/S will be held on Monday March 4, 2024 at 4:00 pm CET at Boege Alle 10-12, 2970 Hoersholm, Denmark.
The Novozymes Report 2023
01:52pm, Thursday, 08'th Feb 2024
This annual report has been released subsequent to the approval of the combination of Novozymes and Chr. Hansen on January 29, 2024.
Novozymes A/S (NVZMF) Q4 2023 Earnings Call Transcript
03:26pm, Thursday, 01'st Feb 2024
Novozymes A/S (NVZMF) Q4 2023 Earnings Call Transcript
Legacy Novozymes delivers solid last full-year results
02:00am, Thursday, 01'st Feb 2024
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for b
Completion of the combination between Novozymes and Chr. Hansen
05:27am, Monday, 29'th Jan 2024
January 29, 2024 – Company announcement no. 2 Please see attachment.
Completion of the combination between Novozymes and Chr. Hansen
05:25am, Monday, 29'th Jan 2024
Please read the full announcement in PDF Attachment 2024_02_Completion_Of_The_Combination
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
06:09am, Friday, 26'th Jan 2024
January 26, 2024 – Company announcement no. 1 Please see attachment.
